local recurrence free survival
Showing 1 - 25 of >10,000
Event-free Survival, Overall Survival, Local-recurrence Free Survival Trial in Beijing (Cisplatin)
Completed
- Event-free Survival
- +3 more
-
Beijing, Beijing, ChinaPeking University People's Hospital
Jan 2, 2021
Prognostic Factors Affecting Recurrence and Disease-Free
Recruiting
- Rectal Cancer
- curative surgery for cancer rectum
-
Qinā, EgyptQena Faculty of Medicine, South Valley University Hospitals
Oct 21, 2023
Circumferential Resection Margin, Intraoperative Perforation of Rectum, Local Recurrence of Malignant Tumor of Rectum Trial in
Recruiting
- Circumferential Resection Margin
- +4 more
- neoadjuvant chemoradiotherapy
-
Beijing, Beijing, ChinaBeijing Chaoyang Hospital
Feb 4, 2021
Disease-free Survival of High-risk Head-neck Cutaneous Squamous
Active, not recruiting
- Carcinoma, Squamous Cell
- +5 more
- Treatment
-
Maastricht, Netherlands
- +1 more
Apr 26, 2023
Colonic Tumors, Tumor Recurrence, Local Trial
Completed
- Colonic Neoplasms
- Neoplasm Recurrence, Local
- (no location specified)
Jul 25, 2022
Rectal Tumors, Tumor Recurrence, Local Trial
Completed
- Rectal Neoplasms
- Neoplasm Recurrence, Local
- (no location specified)
Jul 25, 2022
T1 Squamous Cell Carcinomas of the Lip
Active, not recruiting
- Lip
- +9 more
-
Nijmegen, Gelderland, Netherlands
- +2 more
Nov 2, 2022
Prostate Cancer, Salvage Radiotherapy, Biochemical Recurrence Trial (triptorelin, goserelin, leuprorelin)
Not yet recruiting
- Prostate Cancer
- +4 more
- triptorelin, goserelin, leuprorelin
- (no location specified)
Mar 10, 2023
Esophageal Cancer Trial in Shanghai (Propofol-based total intravenous anesthesia, Sevoflurane intravenous anesthesia)
Recruiting
- Esophageal Cancer
- Propofol-based total intravenous anesthesia
- Sevoflurane intravenous anesthesia
-
Shanghai, ChinaShanhai Chest Hospital
Aug 26, 2021
Colorectal Cancer, Oligometastatic Disease Trial in Australia (Local Ablative Therapy, Standard first-line systemic treatment)
Recruiting
- Colorectal Cancer
- Oligometastatic Disease
- Local Ablative Therapy
- Standard first-line systemic treatment
-
Albury, New South Wales, Australia
- +8 more
May 15, 2023
PD-1 Antibody and Radiotherapy for Recurrent Cervical Cancer
Recruiting
- Immune Checkpoint Inhibitors
- +9 more
- Radiotherapy for targeted lesions and PD-1 antibody
-
Beijing, Beijing, ChinaLei Li
Apr 1, 2022
Recurrence After Whipple's (RAW) Study
Active, not recruiting
- Pancreatic Cancer
- +13 more
- Pancreaticoduodenectomy
-
Clayton, Victoria, Australia
- +28 more
Jan 13, 2023
Status of Surgical Resection and Histologic Subtype as
Completed
- Liposarcoma of Soft Tissue
- Surgical Procedure, Unspecified
- Retroperitoneal Liposarcoma resection
-
São Paulo, BrazilHospital das Clínicas da Faculdade de Medicina da Universidade d
Jun 18, 2022
Liver Metastasis, Colon Cancer Trial in United Kingdom (Icosapent Ethyl, Placebo)
Recruiting
- Liver Metastasis
- Colon Cancer
- Icosapent Ethyl
- Placebo
-
Oxford, Oxfordshire, United Kingdom
- +12 more
Nov 7, 2022
Colorectal Cancer Metastatic Trial in Montpellier, Nîmes (Thermoablation with standard CT guidance, Thermoablation with
Not yet recruiting
- Colorectal Cancer Metastatic
- Thermoablation with standard CT guidance
- Thermoablation with porto-scanner guidance with Angio-CT
-
Montpellier, France
- +1 more
Dec 16, 2022
Chemo Effect, Rectal Cancer Trial in Guangzhou (Radical total mesorectal excision, Salavge Adjuvant Chemoradiotherapy)
Recruiting
- Chemotherapy Effect
- Rectal Cancer
- Radical total mesorectal excision
- Salavge Adjuvant Chemoradiotherapy
-
Guangzhou, Guangdong, ChinaGastrointestinal Hospital, Sun Yat-sen University
Sep 12, 2023
Locally Advanced Breast Cancer Trial in Beijing (Modified radical mastectomy for breast cancer, neoadjuvant therapy, Systematic
Recruiting
- Locally Advanced Breast Cancer
- Modified radical mastectomy for breast cancer
- +2 more
-
Beijing, ChinaYing Xu
Oct 6, 2023
Recurrent Pancreatic Ductal Adenocarcinoma Trial in Amsterdam, Rotterdam, Utrecht (Additional stereotactic body radiation
Enrolling by invitation
- Recurrent Pancreatic Ductal Adenocarcinoma
- Additional stereotactic body radiation therapy
-
Amsterdam, Noord-Holland, Netherlands
- +2 more
May 17, 2022
Centrally Located Hepatocellular Carcinoma, Stereotactic Body Radiotherapy, Hepatectomy Trial in Hangzhou (Neoadjuvant
Not yet recruiting
- Centrally Located Hepatocellular Carcinoma
- +2 more
- Neoadjuvant stereotactic body radiation therapy (Multiple ascending dose) followed by hepatectomy for centrally located hepatocellular carcinoma.
-
Hangzhou, Zhejiang, ChinaThe Second Affiliated Hospital of Zhejiang University School of
Oct 27, 2022
Tumor Bed Boost Radiotherapy in HER2 Positive Breast Cancer
Recruiting
- Breast Cancer
- Whole breast irradiation +/- tumor bed boost
-
Seoul, Korea, Republic ofSamsung Medical Center
May 30, 2023
Thymoma Malignant Recurrent Trial in France (Radiotherapy, Surveillance after resection)
Recruiting
- Thymoma Malignant Recurrent
- Radiotherapy
- Surveillance after resection
-
Angers, France
- +17 more
Aug 8, 2022
Retroperitoneal Sarcoma Trial in Singapore (Doxorubicin)
Recruiting
- Retroperitoneal Sarcoma
-
Singapore, SingaporeNational Cancer Centre Singapore
Jun 10, 2022
Merkel Cell Carcinoma Trial in Wollstonecraft (Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination)
Not yet recruiting
- Merkel Cell Carcinoma
- Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination
-
Wollstonecraft, New South Wales, AustraliaMelanoma Institute Australia
Nov 21, 2023